Acrolein- thioredoxin 1- p38 signaling drives neutrophil-mediated immunosuppression and glioblastoma progression
14 September 2026 at 08:00
Oncogenesis, Published online: 14 September 2026; doi:10.1038/s41389-026-00655-9
Acrolein- thioredoxin 1- p38 signaling drives neutrophil-mediated immunosuppression and glioblastoma progression